The EBITDA of the company has witnessed a marginal growth of 5% in FY21 from FY20, which represents an aggregate increase of Rs. 4 Cr. The overall increase in the EBITDA is attributable to an increase in the revenue of the company
The total revenue of the company in FY21 has witnessed a steady growth of 5% from FY20. An increase in the revenue from operations is attributable to TPA fees, which had risen on account of the COVID-19 pandemic and an increase in health insurance premiums in India, which witnessed 13.3% growth in GDPI in FY21.
EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ Cr
* denotes current year's data